相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms of resistance to immune checkpoint inhibitors
Russell W. Jenkins et al.
BRITISH JOURNAL OF CANCER (2018)
Epacadostat (E) plus pembrolizumab (P) versus pembrolizumab alone in patients (pts) with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/KEYNOTE-252 study.
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pilot trial of an Indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor plus a multipeptide melanoma vaccine in patients with advanced melanoma.
Craig L. Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.
Nathan Bahary et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Russel J. Reiter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Melatonin signaling in T cells: Functions and applications
Wenkai Ren et al.
JOURNAL OF PINEAL RESEARCH (2017)
Herpes Simplex Virus Glycoprotein D Targets a Specific Dendritic Cell Subset and Improves the Performance of Vaccines to Human Papillomavirus-Associated Tumors
Bruna F. M. M. Porchia et al.
MOLECULAR CANCER THERAPEUTICS (2017)
The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells
Holly C. Lewis et al.
ONCOTARGET (2017)
The IDO-Ahr axis controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection
Eliseu Frank de Araujo et al.
FRONTIERS IN IMMUNOLOGY (2017)
Epacadostat plus pembrolizumab in patients with SCCHN: Preliminary phase VII results from ECHO-202/KEYNOTE-037.
Omid Hamid et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
The Importance of Immunization in Cancer Prevention, Treatment, and Survivorship
Elizabeth M. Ward et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation
Roberto Pariente et al.
JOURNAL OF PINEAL RESEARCH (2016)
A phase 2 randomized trial of the 100 pathway inhibitor indoximod in combination with taxane based chemotherapy for metastatic breast cancer: Preliminary data
S-C Tang et al.
CANCER RESEARCH (2016)
Chemotherapy and molecular targeting therapy for recurrent cervical cancer
Naotake Tsuda et al.
CHINESE JOURNAL OF CANCER RESEARCH (2016)
Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8+T cell proliferation by human mesenchymal stromal cells
Jian Hong et al.
CYTOTHERAPY (2016)
Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
Laia Bruni et al.
LANCET GLOBAL HEALTH (2016)
Tolerogenic IDO+ Dendritic Cells Are Induced by PD-1-Expressing Mast Cells
Cecilia Pessoa Rodrigues et al.
FRONTIERS IN IMMUNOLOGY (2016)
Carcinogenic human papillomavirus infection
Mark Schiffman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice
Manabu Takamatsu et al.
CANCER SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Bacillus subtilis spores as adjuvants for DNA vaccines
Luana R. M. M. Aps et al.
VACCINE (2015)
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Rikke B. Holmgaard et al.
CELL REPORTS (2015)
Tryptophan-degrading enzymes in tumoral immune resistance
Nicolas van Baren et al.
FRONTIERS IN IMMUNOLOGY (2015)
Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival
Debbie M. Ferns et al.
ONCOIMMUNOLOGY (2015)
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
Ivan Theate et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells
Raquel Ordonez et al.
JOURNAL OF PINEAL RESEARCH (2014)
Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer
Bruna Victorasso Jardim-Perassi et al.
PLOS ONE (2014)
The role of human papillomavirus in nongenital cancers
Dan P. Zandberg et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity
Tae Heung Kang et al.
CANCER RESEARCH (2013)
The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells
Ana C. R. Moreno et al.
FEBS JOURNAL (2013)
Indoleamine 2,3-Dioxygenase Activity Contributes to Local Immune Suppression in the Skin Expressing Human Papillomavirus Oncoprotein E7
Deepak Mittal et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Cytosolic flagellin-induced lysosomal pathway regulates inflammasome-dependent and -independent macrophage responses
Silvia L. Lage et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development
Courtney Smith et al.
CANCER DISCOVERY (2012)
Purified Herpes Simplex Type 1 Glycoprotein D (gD) Genetically Fused with the Type 16 Human Papillomavirus E7 Oncoprotein Enhances Antigen-Specific CD8+ T Cell Responses and Confers Protective Antitumor Immunity
Brum. F. M. M. Porchia et al.
MOLECULAR PHARMACEUTICS (2011)
Evolving immunosuppressive microenvironment during human cervical carcinogenesis
A. Kobayashi et al.
MUCOSAL IMMUNOLOGY (2008)
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells
Stefan Lob et al.
BLOOD (2008)
Prevention by melatonin of hepatocarcinogenesis in rats injected with N-nitrosodiethylamine
Perumal Subramanian et al.
JOURNAL OF PINEAL RESEARCH (2007)
Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan
Richard Metz et al.
CANCER RESEARCH (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Melatonin in cancer management: Progress and promise
Brittney Jung et al.
CANCER RESEARCH (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Human circadian rhythms: physiological and therapeutic relevance of light and melatonin
Debra J. Skene et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2006)
Cervical cancer: Prevention, diagnosis, and therapeutics
MF Janicek et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2001)
Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines
Y Kanishi et al.
JOURNAL OF PINEAL RESEARCH (2000)
分享论文
